MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0009718
Bio Medica Laboratories Limited
Bio Medica Laboratories Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹38.43 Cr
Latest filing
Net profit · FY 2026
₹11.67 Cr
Net margin 30.4%
EBITDA · FY 2026
₹18.38 Cr
EBITDA margin 47.8%
Authorised capital
₹16 Cr
Registered with MCA
Paid-up capital
₹12.58 Cr
Issued & subscribed
Open charges
₹18.77 Cr
Satisfied ₹3.2 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
7
Provident fund records
About Bio Medica Laboratories Limited
Data last updated:
Bio Medica Laboratories Limited is a public limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U20293MP2015PLC034576. Its GSTIN is 23AAGCB3949J2ZJ (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on NSE: BMLL.
The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹12.58 Cr. It is led by directors including Pradeep Mehta (Managing Director) and Mukesh Mehta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2026, the company reported a revenue of ₹38.43 Cr. For the same year it recorded a net profit of ₹11.67 Cr (net margin 30.4%) and EBITDA of ₹18.38 Cr (EBITDA margin 47.8%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years.
The company has about 7 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹18.77 Cr and satisfied charges of ₹3.2 Cr on record. The company has 1 deal on record (1 ipo); the latest was in May 2026. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Allegro Speciality Chemicals Private Limited with revenue of ₹38.95 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2021, listing 396 overdue payments to 19 micro and small suppliers.
Bio Medica Laboratories Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0009718). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U20293MP2015PLC034576
Registration Number 034576
Incorporation Date 14 August 2015
ROC Gwalior
Listing Status Listed (NSE: BMLL)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0009718
CIN history
Bio Medica Laboratories has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U20293MP2015PLC034576, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U20293MP2015PLC034576 | Current |
| U24230MP2015PLC034576 | Previous |
| U24230MP2015PTC034576 | Previous |
Key People
Pradeep Mehta Managing Director Mukesh Mehta Whole-Time Director Surabhi Mahajan Director Recognitions & Rankings of Bio Medica Laboratories
Contact details
Bio Medica Laboratories Limited's registered office is in Indore, Madhya Pradesh.
- Registered AddressPlot No. 11B – 11C Sector – E, Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452015
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Bio Medica Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bio Medica Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bio Medica Laboratories Limited, buy the company report.
Financials of Bio Medica Laboratories Limited
FY 2025 filings availableBio Medica Laboratories Limited reported revenue of ₹38.43 Cr for FY 2026.
Revenue · FY 2026
₹38.43 Cr
Net profit · FY 2026
₹11.67 Cr margin 30.4%
EBITDA · FY 2026
₹18.38 Cr margin 47.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 33%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 121%
Revenue has grown at a compounded annual rate (CAGR) of 33% over three years. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹38.43 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.38 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11.67 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 47.8% | ||||
| Net Profit Margin | 30.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bio Medica Laboratories Limited, buy the company report.
Board of directors of Bio Medica Laboratories Limited
Bio Medica Laboratories has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Mehta Also directs: Vitamax Healthcare Private Limited | Whole-Time Director | 14 Aug 2015 | 11 Years 2 Months | Current |
| Pradeep Mehta | Managing Director | 14 Aug 2015 | 11 Years 2 Months | Current |
| Surabhi Mahajan | Director | 07 Sep 2024 | 2 Years 1 Months | Current |
| Divya Khandelwal Also directs: Deevyashakti India Private Limited | Director | 28 Oct 2024 | 2 Years 0 Months | Current |
| Sumeet Bansal | Director | 28 Oct 2024 | 2 Years 0 Months | Current |
Peer comparison
Bio Medica Laboratories Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allegro Speciality Chemicals Private Limited | ₹38.95 Cr (FY 2025) | -21.0% | Hyderabad, Telangana, India | |||
| Sigma Laboratories Private Limited | ₹38.91 Cr (FY 2025) | -26.0% | Mumbai, Maharashtra, India | |||
| Revinto Life Science Private Limited | ₹38.71 Cr (FY 2024) | 44.0% | Karwar, Karnataka, India | |||
| Ultra Laboratories Private Limited | ₹38.64 Cr (FY 2024) | 36.0% | Bangalore, Karnataka, India | |||
| Bio Medica Laboratories Limitedthis company | ₹38.43 Cr (FY 2026) | ₹11.67 Cr | 30.4% | Indore, Madhya Pradesh, India | ||
| Fortcaps Healthcare Limited | ₹38.39 Cr (FY 2025) | -7.0% | Gurgaon, Haryana, India | |||
| Medicamen Organics Limited. | ₹38.28 Cr (FY 2025) | 51.0% | New Delhi, Delhi, India | |||
| Diamond Drugs Private Limited | ₹38.26 Cr (FY 2024) | 2.0% | Kolkata, West Bengal, India | |||
| Klar Sehen Pvt Ltd | ₹38.16 Cr (FY 2016) | 18.0% | Bidar, Karnataka, India | |||
| Tulip Lab Private Limited | ₹38.12 Cr (FY 2023) | -78.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Bio Medica Laboratories Limited, buy the company report.
Charges & borrowings
Open charges
₹18.77 Cr
Satisfied charges
₹3.2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Oct 2025 | 101179901 | Bank of India | ₹47 Lakh | Open | |
| 22 Sep 2025 | 101174119 | Hdfc Bank Limited | ₹4.95 Cr | Open | |
| 22 Sep 2025 | 101176560 | Bank of India | ₹24.3 Lakh | Open | |
| 04 Feb 2021 | 100420083 | Others | ₹2.4 Cr | Open | |
| 30 Apr 2019 | 100264029 | Others | ₹10.7 Cr | Open |
To see the full charge records of Bio Medica Laboratories Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Bio Medica Laboratories Limited has 1 deal on record (1 ipo); the latest was in May 2026.
Total deals
1
IPO
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2026 | IPO | ₹52.43 Cr | Investors: Public Market Investors Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Bio Medica Laboratories Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Bio Medica Laboratories Limited has 5 MSME Form 1 returns on record between 2019 and 2021, listing 396 overdue payments to 19 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 19)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ascent Multi Forms Pvt Ltd | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Bhasin Packwell Pvt Ltd |
To see the full MSME payment records of Bio Medica Laboratories Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Bio Medica Laboratories has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAGCB3949J2ZJ | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bio Medica Laboratories Limited, buy the company report.
Recent activity
Bio Medica Laboratories Limited has 11 board changes on record since 2015: 5 appointments and 6 cessations. The latest: Divya Khandelwal ceased to be Additional Director on 10 Nov 2024.
Charges
A charge with Others of Rs. 10.70 Cr registered on 30 Apr 2019 with Charge ID 100264029 was modified on 31 Jul 2026.
Charges
A charge with Others of Rs. 2.40 Cr registered on 04 Feb 2021 with Charge ID 100420083 was modified on 04 Jul 2026.
Charges
A charge with Hdfc Bank Limited of Rs. 4.95 Cr registered on 22 Sep 2025 with Charge ID 101174119 was modified on 02 Dec 2025.
Charges
A charge with Bank Of India amounted to Rs. 0.47 Cr with Charge ID 101179901 was registered on 15 Oct 2025.
AGM
Bio Medica Laboratories Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Bank Of India amounted to Rs. 0.24 Cr with Charge ID 101176560 was registered on 22 Sep 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.95 Cr with Charge ID 101174119 was registered on 22 Sep 2025.
Filing
Bio Medica Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge registered on 21 Oct 2017 via Charge ID 100154898 with Others was fully satisfied on 17 Mar 2025.
Ceased
Divya Khandelwal ceased to be Additional Director.
Ceased
Sumeet Bansal ceased to be Additional Director.
Appointed
Divya Khandelwal was appointed as Director.
22 earlier events are in the company report.
Frequently asked questions
Bio Medica Laboratories is an active public limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 August 2015 (11+ years old) and is registered under CIN U20293MP2015PLC034576. Listed on NSE: BMLL.
Bio Medica Laboratories has 5 current directors:
- Pradeep Mehta - Managing Director
- Mukesh Mehta - Whole-Time Director
- Surabhi Mahajan - Director
- Divya Khandelwal - Director
- Sumeet Bansal - Director
The latest financial statements of Bio Medica Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Bio Medica Laboratories is 23AAGCB3949J2ZJ, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Bio Medica Laboratories is U20293MP2015PLC034576. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Bio Medica Laboratories is a listed company as per MCA records. Its shares are listed on NSE (symbol: BMLL).
Bio Medica Laboratories was incorporated on 14 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Gwalior.
Bio Medica Laboratories has 1 deal on record (1 ipo); the latest was in May 2026.
The peers of Bio Medica Laboratories by revenue are Allegro Speciality Chemicals Private Limited, Sigma Laboratories Private Limited, Revinto Life Science Private Limited, Ultra Laboratories Private Limited, Fortcaps Healthcare Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Divya Khandelwal ceased to be Additional Director on 10 Nov 2024. Sumeet Bansal ceased to be Additional Director on 10 Nov 2024. Divya Khandelwal was appointed as Director on 28 Oct 2024. Bio Medica Laboratories has 11 board changes on record in total.
Yes, Bio Medica Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0009718).
Bio Medica Laboratories has 5 MSME Form 1 returns on record between 2019 and 2021, listing 396 overdue payments to 19 micro and small suppliers. The latest return was filed on 08 Sep 2021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages